Diagnosis and management of hepatic encephalopathy :
General Material Designation
[Book]
Other Title Information
a case-based guide /
First Statement of Responsibility
Jasmohan S. Bajaj, editor.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Cham, Switzerland :
Name of Publisher, Distributor, etc.
Springer,
Date of Publication, Distribution, etc.
[2018]
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index.
CONTENTS NOTE
Text of Note
Intro; Preface; Acknowledgments; Contents; Contributors; Chapter 1: Definition and Changes in Nomenclature of Hepatic Encephalopathy; Definition; Current Issues with Nomenclature of HE; Classification; Case 1; Case 2; Case 3; Case 4; Case 5; Conclusion; References; Chapter 2: Hepatic Encephalopathy: Pathophysiology-Brain; Clinical Scenario; Causes of Hyperammonemia; Neurotoxicity of Ammonia; Systemic Inflammation and Oxidative Stress; Impact of Recurrent HE; Conclusion; References; Chapter 3: Pathophysiology: Gut Liver Axis Changes; Clinical Scenario: Part 1; Ammonia.
Text of Note
Chapter 7: Prevention of Recurrence of Hepatic EncephalopathyIntroduction; Luminal Agents; Nonabsorbable Disaccharides; Rifaximin; Probiotics; Extraluminal Agents; Glycerol Phenylbutyrate; Branched-Chain Amino Acids (BCAA); Interventions; Embolization of Large Spontaneous Shunt; Balloon-Occluded Retrograde Transvenous Obliteration; Conclusion; References; Chapter 8: Hepatic Encephalopathy Diagnosis Conundrums; Introduction; Instead of HE 1: Seizure in Compensated Cirrhosis and Cerebrovascular Disease; Instead of HE 2: Viral Encephalitis in Decompensated Cirrhosis.
Text of Note
Clinical Scenario: Part 2Infection and Inflammation; Clinical Scenario: Part 3; The Gut Microbiome; Modifying the Gut Microbiota May Be Expected to Alter Outcomes in HE; Conclusions; References; Chapter 4: Impact and Diagnosis of Minimal or Grade 1 Hepatic Encephalopathy; Introduction; Portosystemic Encephalopathy Test (PSE); The Continuous Reaction Time Test (CRT); Case 1: HE with No Comorbidity; Winter 2016; Summer 2017; Autumn 2017; Winter 2017; Case 2: Recurrent HE with Co-morbid Medical Diseases; The Impact of Minimal and Grade 1 HE; Diagnosing Minimal and Grade 1 Hepatic Encephalopathy.
Text of Note
Isolated Hepatic EncephalopathyHepatic Encephalopathy Associated with Acute-on-Chronic Liver Failure; Pathophysiology of Hepatic Encephalopathy in Acute-on-Chronic Liver Failure; Management of Hepatic Encephalopathy in the Hospitalized Patient; General Approach; Direct Treatment at Precipitating Factors; Specific Treatment; Nonabsorbable Disaccharides; Rifaximin; Neomycin, Metronidazole, and Vancomycin; Zinc; l-Ornithine l-Aspartate; Branched-Chain Amino Acids; Percutaneous Embolization of Large Portosystemic Shunts; Molecular Adsorbent Recirculating System; Liver Transplantation; References.
0
8
8
8
SUMMARY OR ABSTRACT
Text of Note
This volume provides a comprehensive, state-of-the-art overview of hepatic encephalopathy. Through a case-based approach, the text reviews new data and studies about the role of microbiota in liver disease and hepatic encephalopathy, explores the burden of hepatic encephalopathy on readmissions, costs, and patient care, and highlights management strategies for patients in differing stages of hepatic encephalopathy. Exploratory new therapies and treatment targets are also discussed in the guide. Written by experts in the field, Diagnosis and Management of Hepatic Encephalopathy: A Case-based Guide is a valuable resource for physicians and researchers who deal with this challenging complication of cirrhosis.
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Springer Nature
Stock Number
com.springer.onix.9783319767987
OTHER EDITION IN ANOTHER MEDIUM
Title
Diagnosis and management of hepatic encephalopathy.